Cambridge Bio-Augmentation Systems | Runner-up in Healthcare Category
Cambridge Bio-Augmentation Systems is attempting to create a common standard, a sort of USB connector for the body. The company calls this the Prosthetic Interface Device, or PID, and says it will increase the accessibility, functionality and effectiveness of bionic limbs. Its mission is to create the open standard platform to support high functionality neural and bionic treatments, making it easy for clinicians, engineers and researchers to develop and deliver superior treatments to patients.
The nervous system carries electrical impulses to control virtually every organ and bodily function. Many common chronic conditions often occur as a result of a failure or change in our neural pathways. Cambridge says if it can understand and correct these signals in real time, for each individual patient, the company can treat chronic illnesses in an effective, automated, and personalized way.
Cambridge says it has generated the world’s largest neural dataset, gathered from pre-clinical trials. The company is exploring how it can understand nerve signals in the limbs and interpret movements through machine learning and AI-and applying these methods to autonomic nervous signals to learn about general health patterns and abnormalities.